Public Bidding Announcement for the High-Throughput CHO Expression Antibody Gene Technology Service Project (zycgr21071301)
About This Opportunity
This is a services contract in the health and medical services, Research and audit and accounting sectors, with a focus on Asset Valuation. Located in China, Asia, this opportunity is open to firms and consortiums.
Published through China CCGP, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. Interested parties should review the full documentation on the original source before submitting their proposal.
Description
Original language: ChineseThis tender announces an open bidding process for high-throughput CHO expression antibody gene technology services. The procurement is managed by Oriental International Tendering Co., Ltd. on behalf of the contracting entity identified as zycgr21071301 in China. The objective is to secure specialized technical services related to the generation and expression of antibody genes using Chinese Hamster Ovary (CHO) cell lines, a common platform in biopharmaceutical development. Typical requirements for such a service tender include detailed protocols for gene synthesis, vector construction, cell line development, transfection, screening, and expression optimization. Bidders are expected to demonstrate extensive experience in antibody discovery and development, particularly with CHO expression systems. The tender likely specifies deliverables such as antibody sequences, expression data, and potentially small-scale production of the target antibody. Evaluation will focus on the technical expertise of the service provider, the proposed methodology, project timelines, intellectual property considerations, and cost.
This procurement is crucial for advancing research and development in the biopharmaceutical sector.
Data provenance
This notice is sourced from China CCGP and was originally published on August 3, 2026. Last refreshed today. Original language: Chinese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
Frequently asked questions about this tender
What type of contract is this?
This is a Services contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Where will the contract be performed?
The contract is for delivery in China. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit China CCGP to access the full notice, required documents, and submission instructions provided by the contracting authority.
Who is the contracting authority?
This notice was issued by zycgr21071301 in China. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.
Sectors & Categories
Contracting Authority
Companies That Won Similar
Companies with awards in Health & Medical in China